SLC9A1 and heart failure: However, that study was not based on target identification experiments validating a direct molecular interaction between EMPA and NHE1; rather, it identified that an inhibition of NHE1 by EMPA would indeed be beneficial in heart failure, assuming that such interaction exists based on published data.